These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7216893)

  • 1. Immunomodulatory effects of levamisole.
    Brunner CJ; Muscoplat CC
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1159-62. PubMed ID: 7216893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levamisole in chronic inflammatory diseases.
    Wilton JM
    J Rheumatol Suppl; 1978; 4():101-13. PubMed ID: 366135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of the administration of levamisole on the reactivity of T-lymphocytes in advanced cancer patients].
    Renoux G; Renoux M
    Nouv Presse Med; 1976 Jan; 5(2):67-70. PubMed ID: 772602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levamisole, stimulant of the immune system in animal and man (author's transl)].
    Andrieu JM
    Pathol Biol (Paris); 1977 Jan; 25(1):57-66. PubMed ID: 322037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of levamisole on cell-mediated immunity and suppressor cell function.
    Sampson D; Lui A
    Cancer Res; 1976 Mar; 36(3):952-5. PubMed ID: 1253182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of levamisole treatment in old people.
    Rossi ER; Librace E; Barocci S
    Boll Soc Ital Biol Sper; 1981 Jan; 57(2):202-6. PubMed ID: 7236393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects.
    Luyckx M; Cazin M; Brunet C; Cazin JC; Devulder B; Gosselin P; Adenis L; Cappelaere P; Granier AM; Demaille A
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):467-9. PubMed ID: 6608036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of levamisole on the immunological reactivity of patients with chronic postoperative osteomyelitis].
    Linnik SA; Dzhaginian AI; Andreeva LN; Koz'mina-Sokolova IB
    Vestn Khir Im I I Grek; 1985 Sep; 135(9):51-4. PubMed ID: 4071910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children.
    Demirci F; Bayraktaroğlu Z; Karaoğlan M; Coşkun Y; Karaoğlan I; Okan V
    Turk J Gastroenterol; 2005 Dec; 16(4):188-93. PubMed ID: 16547845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulators--thymus factor X (TFX) and levamisole in immune reactions and inflammatory processes.
    Giełdanowski J
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):121-32. PubMed ID: 7305628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunobiological properties of trimezon and levamisole on models of humoral and cell-mediated immunogenesis].
    Liubin GS; Kuz'mitskiĭ BB
    Eksp Klin Farmakol; 1997; 60(1):50-2. PubMed ID: 9162286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole.
    Spitler LE
    Cutis; 1977 Jun; 19(6):719, 728-32. PubMed ID: 872616
    [No Abstract]   [Full Text] [Related]  

  • 13. A hypothesis. The mechanism of action of levamisole: immune restoration through enhanced cell maturation.
    Amery WK
    J Reticuloendothel Soc; 1978 Aug; 24(2):187-93. PubMed ID: 309007
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of levamisole on various indicators of cellular immunity in amyloidosis].
    Khasabov NN; Mukhin NA; Sura VV; Osipova IN; Varshavskiĭ VA
    Ter Arkh; 1978; 50(2):115-9. PubMed ID: 644475
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II; Skakal'skaia LM
    Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modes of action of levamisole].
    Renoux G
    Nouv Presse Med; 1977 Nov; 6(38):3552. PubMed ID: 304562
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cellular immunity in tuberculosis. Value of levamisole (proceedings)].
    Tanphaichitra D
    Bull Int Union Tuberc; 1979 Jun; 54(2):175-6. PubMed ID: 526649
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of levamisole as an immunomodulating agent in trophoblastic lesions.
    Khanna A; Ojha KN; Gupta RM
    Indian J Pathol Microbiol; 1993 Jan; 36(1):32-7. PubMed ID: 8354552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levamisole--a non-specific immunostimulant].
    Soppi E; Ruuskanen O; Toivanen A
    Duodecim; 1976; 92(21):1203-5. PubMed ID: 991773
    [No Abstract]   [Full Text] [Related]  

  • 20. Mode of action of levamisole.
    Goldstein G
    J Rheumatol Suppl; 1978; 4():143-8. PubMed ID: 310464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.